Management of Sleep Disturbances and Agitation in Dementia Patients

Introduction to Dementia Care

The Canadian Consensus Conference on Dementia explicitly recommends minimizing exposure to medications with anticholinergic properties in older persons, and hydroxyzine falls squarely into this category 1
Anticholinergic medications like hydroxyzine, diphenhydramine, and oxybutynin worsen confusion, agitation, and cognitive function in dementia patients 1, 2
Over-the-counter antihistamines (including hydroxyzine) have very high rates of side effects, including cognitive impairment, daytime somnolence, and anticholinergic responses 3

Implement bright light therapy during morning hours (09:00-11:00) for 1-2 hours daily at 2,500-5,000 lux, positioned about 1 meter from the patient 1
Create a sleep-conducive environment by reducing nighttime light and noise, and improve incontinence care to minimize nighttime awakenings 1
Establish a structured bedtime routine and encourage at least 30 minutes of sunlight exposure daily 1
Increase physical and social activities during daytime hours, and reduce time spent in bed during the day 1

SSRIs are the preferred first-line pharmacological option for chronic agitation without psychotic features: citalopram 10 mg/day (maximum 40 mg/day) or sertraline 25-50 mg/day (maximum 200 mg/day) 2
Trazodone 25 mg/day (maximum 200-400 mg/day) is a second-line option if SSRIs fail, though use caution due to orthostatic hypotension risk 2
Antipsychotics should only be used when the patient is severely agitated, threatening substantial harm to self or others, and behavioral interventions have failed 2
Risperidone 0.25-0.5 mg at bedtime (maximum 1-2 mg/day) is first-line, with quetiapine 12.5-25 mg twice daily as an alternative 2
All antipsychotics increase mortality risk 1.6-1.7 times higher than placebo in elderly dementia patients—this must be discussed with the patient's surrogate decision maker before initiation 2

Never use hydroxyzine or other anticholinergic antihistamines (diphenhydramine, promethazine) in dementia patients 1, 2
Avoid benzodiazepines except for alcohol or benzodiazepine withdrawal, as they increase delirium incidence and duration and cause paradoxical agitation in approximately 10% of elderly patients 1, 2
Do not use antipsychotics for mild agitation or behaviors like unfriendliness, poor self-care, repetitive questioning, or wandering—these are unlikely to respond to psychotropics 2
Avoid typical antipsychotics (haloperidol, fluphenazine) as first-line therapy due to 50% risk of tardive dyskinesia after 2 years of continuous use in elderly patients 2